Showing 1 - 20 results of 142 for search 'D A. Sychev', query time: 0.05s
Refine Results
-
1
Clinical and pharmacological technologies of personalized medicine: what now and what will happen? by D. A. Sychev
Published 2019-12-01
Article -
2
-
3
Review of the book “Practical issues of rational antibacterial therapy” by D. A. Sychev
Published 2024-02-01
Article -
4
Change of opinion on the use of hydroxychloroquine for COVID-19 treatment and prevention by K. B. Mirzaev, D. A. Sychev
Published 2020-10-01
Article -
5
Genetic determinants of indirect anticoagulants’ sensitivity: VKORC1 and APOE gene polymorphism by D. A. Sychev, I. V. Ignatyev
Published 2005-10-01
Article -
6
-
7
ARE ALL THE PROLONGED DRUG FORMULATIONS OF NIFEDIPINE THE SAME? by V. G. Kukes, D. A. Sychev
Published 2016-01-01
Article -
8
Organo-protective effects of quinapril: pharmacogenetic aspects by D. A. Sychev, O. V. Muslimova
Published 2011-04-01
Article -
9
-
10
Deprescribing Antihypertensive Drugs in Patients of Older Age Groups by O. D. Ostroumova, M. S. Cherniaeva, D. A. Sychev
Published 2020-03-01
Article -
11
-
12
Genetic Risk Factors for Adverse Drug Reactions by D. A. Sychev, M. S. Chernyaeva, O. D. Ostroumova
Published 2022-04-01
Article -
13
Possibilities for the use of tofacitinib in patients with COVID-19 by A. V. Matveev, Yu. Yu. Kiselev, D. A. Sychev
Published 2020-10-01
Article -
14
Current and future use of remdesivir in patients with COVID-19 by V. M. Tsvetov, K. B. Mirzaev, D. A. Sychev
Published 2020-10-01
Article -
15
-
16
Genetic determinants of indirect anticoagulants’ sensitivity: VKORC1 and APOE gene polymorphism by D. A. Sychev, I. V. Ignatyev, V. G. Kukes
Published 2005-10-01
Article -
17
Rationality of routine clinical use of olokizumab in COVID-19 by V. M. Tsvetov, A. V. Matveev, D. A. Sychev
Published 2020-10-01
Article -
18
-
19
-
20
Taxanes induced peripheral neuropathy: mechanism of development and pharmacogenetic factors by L V Shestakova, D A Sychev, I V Poddubnaya
Published 2018-03-01
Article